+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy

The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy

Proceedings of the National Academy of Sciences of the United States of America 104(24): 10140

In response to various pathological stresses, the heart undergoes a pathological remodeling process that is associated with cardiomyocyte hypertrophy. Because cardiac hypertrophy can progress to heart failure, a major cause of lethality worldwide, the intracellular signaling pathways that control cardiomyocyte growth have been the subject of intensive investigation. It has been known for more than a decade that the small molecular weight GTPase RhoA is involved in the signaling pathways leading to cardiomyocyte hypertrophy. Although some of the hypertrophic pathways activated by RhoA have now been identified, the identity of the exchange factors that modulate its activity in cardiomyocytes is currently unknown. In this study, we show that AKAP-Lbc, an A-kinase anchoring protein (AKAP) with an intrinsic Rho-specific guanine nucleotide exchange factor activity, is critical for activating RhoA and transducing hypertrophic signals downstream of alpha1-adrenergic receptors (ARs). In particular, our results indicate that suppression of AKAP-Lbc expression by infecting rat neonatal ventricular cardiomyocytes with lentiviruses encoding AKAP-Lbc-specific short hairpin RNAs strongly reduces both alpha1-AR-mediated RhoA activation and hypertrophic responses. Interestingly, alpha1-ARs promote AKAP-Lbc activation via a pathway that requires the alpha subunit of the heterotrimeric G protein G12. These findings identify AKAP-Lbc as the first Rho-guanine nucleotide exchange factor (GEF) involved in the signaling pathways leading to cardiomyocytes hypertrophy.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056161271

Download citation: RISBibTeXText

PMID: 17537920

DOI: 10.1073/pnas.0701099104

Related references

The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates l1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proceedings of the National Academy of Sciences of the United States of America 12 104(24): 10140-10145, 2007

A-kinase anchoring protein (AKAP)-Lbc anchors a PKN-based signaling complex involved in α1-adrenergic receptor-induced p38 activation. Journal of Biological Chemistry 286(10): 7925-7937, 2011

Compartmentalization role of A-kinase anchoring proteins (AKAPs) in mediating protein kinase A (PKA) signaling and cardiomyocyte hypertrophy. International Journal of Molecular Sciences 16(1): 218-229, 2014

Alpha1-Adrenergic receptor-induced cardiomyocyte hypertrophy is mediated by Galpha12/13 as well as Galphaq. Circulation 104(17 Suppl.): II 198, 2001

Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Current Biology 10(7): 409-412, 2000

Role of inositol 1,4,5-trisphosphate receptors in alpha1-adrenergic receptor-induced cardiomyocyte hypertrophy. Acta Pharmacologica Sinica 27(7): 895-900, 2006

Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circulation Research 102(8): 959-965, 2008

Analysis of A-kinase anchoring protein (AKAP) interaction with protein kinase A (PKA) regulatory subunits: PKA isoform specificity in AKAP binding. Journal of Molecular Biology 298(2): 329-339, 2000

Distinct G protein-dependence for hypertrophic signaling by cardiomyocyte alpha1-adrenergic receptors and protease-activated receptor-1. Circulation 102(18 Suppl.): II 198, 2000

Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heart. Journal of Biological Chemistry 287(48): 40535-40546, 2012

Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway. Basic Research in Cardiology 104(6): 653-667, 2009

Beta-Adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: Regulation by beta- but not alpha1-adrenergic stimulation. Hypertension 33(1 Part 2): 396-401, 1999

AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex. Journal of Biological Chemistry 277(52): 50885-50892, 2002

A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy. Molecular and Cellular Biology 33(1): 14-27, 2013

A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy. Molecular and Cellular Biology 33(15): 2903-2917, 2013